• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

常染色体显性遗传性多囊肾病患儿的人口统计学和临床特征:单中心经验。

Demographic and clinical characteristics of children with autosomal dominant polycystic kidney disease: a single center experience.

机构信息

Department of Pediatrics, Division of Nephrology and Rheumatology, İzmir Katip Çelebi University, İzmir, Turkey

Department of Pediatrics Division of Nephrology, Tepecik Training and Research Hospital, Health Sciences University, İzmir, Turkey

出版信息

Turk J Med Sci. 2021 Apr 30;51(2):772-777. doi: 10.3906/sag-2009-79.

DOI:10.3906/sag-2009-79
PMID:33315352
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8203125/
Abstract

BACKGROUND/AIM: In children with autosomal dominant polycystic kidney disease (ADPKD), clinical manifestations range from severe neonatal presentation to renal cysts found by chance. We aimed to evaluate demographic, clinical, laboratory findings, and genetic analysis of children with ADPKD.

MATERIALS AND METHODS

We evaluated children diagnosed with ADPKD between January 2006 and January 2019. The diagnosis was established by family history, ultrasound findings, and/or genetic analysis. The demographic, clinical, and laboratory findings were evaluated retrospectively. Patients <10 years and ≥10 years at the time of diagnosis were divided into 2 groups and parameters were compared between the groups.

RESULTS

There were 41 children (M/F: 18/23) diagnosed with ADPKD. The mean age at diagnosis was 7.2 ± 5.1 (0.6–16.9) years and the follow-up duration was 59.34 ± 40.56 (8–198) months. Five patients (12%) were diagnosed as very early onset ADPKD. All patients had a positive family history. Genetic analysis was performed in 29 patients (PKD1 mutations in 21, PKD2 mutations in 1, no mutation in 3). Cysts were bilateral in 35 (85%) of the patients. Only one patient had hepatic cysts. No valvular defect was defined in 12 patients detected. Only 1 patient had hypertension. None of them had chronic kidney disease. No difference could be demonstrated in sex, laterality of the cysts, maximum cyst diameter, cyst or kidney enlargement, follow-up duration, or GFR at last visit between Groups 1 and 2.

CONCLUSION

The majority of children with ADPKD had preserved renal functions and slight cyst enlargement during their follow-up. However, they may have different renal problems deserving closed follow-up.

摘要

背景/目的:常染色体显性遗传性多囊肾病(ADPKD)患儿的临床表现范围从严重的新生儿表现到偶然发现的肾囊肿不等。我们旨在评估 ADPKD 患儿的人口统计学、临床、实验室检查结果和基因分析。

材料和方法

我们评估了 2006 年 1 月至 2019 年 1 月期间诊断为 ADPKD 的儿童。通过家族史、超声检查结果和/或基因分析确定诊断。回顾性评估人口统计学、临床和实验室检查结果。将诊断时年龄<10 岁和≥10 岁的患者分为 2 组,并对组间参数进行比较。

结果

共诊断出 41 例 ADPKD 患儿(男/女:18/23)。诊断时的平均年龄为 7.2±5.1(0.6-16.9)岁,随访时间为 59.34±40.56(8-198)个月。5 例(12%)患者诊断为极早发性 ADPKD。所有患者均有阳性家族史。对 29 例患者进行了基因分析(PKD1 突变 21 例,PKD2 突变 1 例,无突变 3 例)。35 例患者(85%)为双侧囊肿。仅 1 例患者有肝囊肿。在 12 例被检测的患者中未发现瓣膜缺陷。仅 1 例患者有高血压。他们均无慢性肾脏病。最后一次就诊时,两组间的性别、囊肿的侧别、最大囊肿直径、囊肿或肾脏增大、随访时间或肾小球滤过率均无差异。

结论

大多数 ADPKD 患儿在随访期间肾功能正常,囊肿轻度增大。然而,他们可能存在需要密切随访的不同肾脏问题。

相似文献

1
Demographic and clinical characteristics of children with autosomal dominant polycystic kidney disease: a single center experience.常染色体显性遗传性多囊肾病患儿的人口统计学和临床特征:单中心经验。
Turk J Med Sci. 2021 Apr 30;51(2):772-777. doi: 10.3906/sag-2009-79.
2
Relationship of Seminal Megavesicles, Prostate Median Cysts, and Genotype in Autosomal Dominant Polycystic Kidney Disease.常染色体显性遗传多囊肾病中精囊大囊泡、前列腺中位囊肿与基因型的关系。
J Magn Reson Imaging. 2019 Mar;49(3):894-903. doi: 10.1002/jmri.26289. Epub 2018 Sep 19.
3
Pancreatic Cysts in Autosomal Dominant Polycystic Kidney Disease: Prevalence and Association with PKD2 Gene Mutations.常染色体显性多囊肾病中的胰腺囊肿:患病率及与PKD2基因突变的关联
Radiology. 2016 Sep;280(3):762-70. doi: 10.1148/radiol.2016151650. Epub 2016 Apr 5.
4
Growth Pattern of Kidney Cyst Number and Volume in Autosomal Dominant Polycystic Kidney Disease.常染色体显性多囊肾病中肾囊肿数量和体积的生长模式。
Clin J Am Soc Nephrol. 2019 Jun 7;14(6):823-833. doi: 10.2215/CJN.10360818. Epub 2019 May 14.
5
Kidney enlargement and multiple liver cyst formation implicate mutations in PKD1/2 in adult sporadic polycystic kidney disease.肾脏增大和多个肝囊肿形成提示成人散发性多囊肾病与 PKD1/2 基因突变有关。
Clin Genet. 2018 Jul;94(1):125-131. doi: 10.1111/cge.13249. Epub 2018 Apr 11.
6
Imaging features of tuberous sclerosis complex with autosomal-dominant polycystic kidney disease: a contiguous gene syndrome.结节性硬化症合并常染色体显性多囊肾病的影像学特征:一种相邻基因综合征
Pediatr Radiol. 2015 Mar;45(3):386-95. doi: 10.1007/s00247-014-3147-1. Epub 2014 Oct 30.
7
Mutational analysis in patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD): Identification of five mutations in the PKD1 gene.常染色体显性多囊肾病(ADPKD)患者的突变分析:PKD1 基因中的五个突变的鉴定。
Gene. 2018 Sep 10;671:28-35. doi: 10.1016/j.gene.2018.05.112. Epub 2018 Jun 1.
8
PKD2-Related Autosomal Dominant Polycystic Kidney Disease: Prevalence, Clinical Presentation, Mutation Spectrum, and Prognosis.与PKD2相关的常染色体显性多囊肾病:患病率、临床表现、突变谱及预后
Am J Kidney Dis. 2017 Oct;70(4):476-485. doi: 10.1053/j.ajkd.2017.01.046. Epub 2017 Mar 27.
9
Aberrant PKD2 splicing due to a presumed novel missense mutation in autosomal-dominant polycystic kidney disease.常染色体显性遗传性多囊肾病中假定的新型错义突变导致 PKD2 剪接异常。
Clin Genet. 2011 Sep;80(3):287-92. doi: 10.1111/j.1399-0004.2010.01555.x. Epub 2010 Oct 18.
10
Somatic Mutations in Renal Cyst Epithelium in Autosomal Dominant Polycystic Kidney Disease.常染色体显性多囊肾病中肾囊肿上皮的体细胞突变。
J Am Soc Nephrol. 2018 Aug;29(8):2139-2156. doi: 10.1681/ASN.2017080878. Epub 2018 Jul 24.

引用本文的文献

1
Kidney Measurement and Glomerular Filtration Rate Evolution in Children with Polycystic Kidney Disease.多囊肾病患儿的肾脏测量与肾小球滤过率演变
Children (Basel). 2024 May 10;11(5):575. doi: 10.3390/children11050575.
2
The genetic spectrum of polycystic kidney disease in children.儿童多囊肾病的遗传谱。
Rev Assoc Med Bras (1992). 2023 Oct 27;69(11):e20230334. doi: 10.1590/1806-9282.20230334. eCollection 2023.

本文引用的文献

1
Tolvaptan use in children and adolescents with autosomal dominant polycystic kidney disease: rationale and design of a two-part, randomized, double-blind, placebo-controlled trial.托伐普坦在常染色体显性遗传多囊肾病患儿和青少年中的应用:一项两部分、随机、双盲、安慰剂对照试验的原理和设计。
Eur J Pediatr. 2019 Jul;178(7):1013-1021. doi: 10.1007/s00431-019-03384-x. Epub 2019 May 3.
2
Clinical practice guideline monitoring children and young people with, or at risk of developing autosomal dominant polycystic kidney disease (ADPKD).监测患有常染色体显性多囊肾病(ADPKD)或有患该病风险的儿童和青少年的临床实践指南。
BMC Nephrol. 2019 Apr 30;20(1):148. doi: 10.1186/s12882-019-1285-2.
3
Unmet needs and challenges for follow-up and treatment of autosomal dominant polycystic kidney disease: the paediatric perspective.常染色体显性多囊肾病随访与治疗中未满足的需求及挑战:儿科视角
Clin Kidney J. 2018 Dec;11(Suppl 1):i14-i26. doi: 10.1093/ckj/sfy088. Epub 2018 Dec 17.
4
Is Autosomal Dominant Polycystic Kidney Disease Becoming a Pediatric Disorder?常染色体显性多囊肾病正在成为一种儿科疾病吗?
Front Pediatr. 2017 Dec 20;5:272. doi: 10.3389/fped.2017.00272. eCollection 2017.
5
Screening for intracranial aneurysms in autosomal dominant polycystic kidney disease is cost-effective.在常染色体显性多囊肾病中筛查颅内动脉瘤具有成本效益。
Kidney Int. 2018 Mar;93(3):716-726. doi: 10.1016/j.kint.2017.08.016. Epub 2017 Oct 20.
6
Tolvaptan treatment for severe neonatal autosomal-dominant polycystic kidney disease.托伐普坦治疗重症新生儿常染色体显性多囊肾病
Pediatr Nephrol. 2017 May;32(5):893-896. doi: 10.1007/s00467-017-3584-9. Epub 2017 Feb 13.
7
Hypertension in autosomal dominant polycystic kidney disease: a meta-analysis.常染色体显性多囊肾病中的高血压:一项荟萃分析。
Arch Dis Child. 2016 Dec;101(12):1142-1147. doi: 10.1136/archdischild-2015-310221. Epub 2016 Jun 10.
8
The spectrum of autosomal dominant polycystic kidney disease in children and adolescents.儿童和青少年常染色体显性多囊肾病的谱系
Pediatr Nephrol. 2017 Jan;32(1):31-42. doi: 10.1007/s00467-016-3364-y. Epub 2016 Mar 31.
9
Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice.托伐普坦用于常染色体显性遗传性多囊肾病的建议:代表欧洲肾脏病学会-欧洲透析与移植协会遗传性肾脏疾病工作组及欧洲肾脏最佳实践发布的立场声明
Nephrol Dial Transplant. 2016 Mar;31(3):337-48. doi: 10.1093/ndt/gfv456. Epub 2016 Jan 29.
10
Increased psychosocial risk, depression and reduced quality of life living with autosomal dominant polycystic kidney disease.常染色体显性多囊肾病患者的心理社会风险增加、抑郁及生活质量下降。
Nephrol Dial Transplant. 2016 Jul;31(7):1130-40. doi: 10.1093/ndt/gfv299. Epub 2015 Aug 12.